Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease

Y Wang, Z Sui, M Wang, P Liu - Frontiers in Immunology, 2023 - frontiersin.org
Diabetic kidney disease (DKD) is a prevalent and severe complications of diabetes and
serves as the primary cause of end-stage kidney disease (ESKD) globally. Increasing …

Exploring the role of NLRP3 inflammasome in diabetic nephropathy and the advancements in herbal therapeutics

J Jin, M Zhang - Frontiers in Endocrinology, 2024 - frontiersin.org
Diabetic nephropathy (DN), a prevalent complication of diabetes mellitus (DM), is clinically
marked by progressive proteinuria and a decline in glomerular filtration rate. The etiology …

Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches

C Ram, AK Jha, A Ghosh, S Gairola, AM Syed… - European journal of …, 2020 - Elsevier
Diabetes mellitus is an increasingly prevalent disease around the globe. The epidemic of
diabetes mellitus and its complications pretenses the foremost health threat globally …

The selective NLRP3-inflammasome inhibitor CY-09 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3-inflammasome activation

M Yang, L Zhao - Current medicinal chemistry, 2023 - ingentaconnect.com
Background: Diabetic nephropathy (DN) is one of the most serious complications of diabetes
mellitus and the main cause of the end-stage renal disease (ESRD). Activation of the NLRP3 …

Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome

F Chen, G Wei, J Xu, X Ma, Q Wang - BMC Complementary and …, 2018 - Springer
Abstract Background The Nucleotide binding and oligomerization domain-like
receptorfamily pyrin domain-containing 3 (NLRP3)-inflammasome plays an important role in …

Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys

H Yaribeygi, N Katsiki, AE Butler, A Sahebkar - Drug discovery today, 2019 - Elsevier
Highlights•NLRP3 inflammasome activity plays an important role in inflammatory
responses.•NLRP3 inflammasome is also implicated in diabetic nephropathy (DN) …

Role of NLRP3 inflammasome in lupus nephritis and therapeutic targeting by phytochemicals

D Wu, L Ai, Y Sun, B Yang, S Chen, Q Wang… - Frontiers in …, 2021 - frontiersin.org
Systemic lupus erythematosus (SLE) is a multisystem autoimmune inflammatory condition
that affects multiple organs and provokes extensive and severe clinical manifestations …

Targeting the NLRP3 inflammasome in diabetic nephropathy

M Yang, X Wang, Y Han, C Li, L Wei… - Current medicinal …, 2021 - ingentaconnect.com
Diabetic nephropathy (DN) is one of the most common complications of diabetes and the
main cause of end-stage renal disease (ESRD). The inflammatory response plays a key role …

[HTML][HTML] Targeting NLRP3 inflammasome in the treatment of diabetes and diabetic complications: Role of natural compounds from herbal medicine

Y Bai, Q Mu, X Bao, J Zuo, X Fang, J Hua… - Aging and …, 2021 - ncbi.nlm.nih.gov
Diabetes, a common metabolic disease with various complications, is becoming a serious
global health pandemic. So far there are many approaches in the management of diabetes; …

TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy

J Shen, Z Dai, Y Li, H Zhu, L Zhao - Diabetology & metabolic syndrome, 2022 - Springer
Abstract Background Toll-like receptors (TLRs) are critical sensors for the conservation of
bacterial molecules and play a key role in host defense against pathogens. The effect of …